Analysis and Perspectives

Jul 25, 2024

BMS has established a comprehensive treatment strategy, with CELMODs replacing REVLIMID in earlier lines of multiple myeloma treatment.

May 29, 2024

Artificial blood vessels represent a critical frontier in medical research, offering significant promise for treating cardiovascular diseases and enhancing surgical outcomes. Future directions in this field are focused on developing materials that can closely mimic the natural properties of human blood vessels.

May 22, 2024

The future directions for the surgical camera market are promising, with a focus on enhancing image quality, reducing costs, and improving ease of use. Innovations such as 3D imaging, robotic integration, and artificial intelligence are expected to revolutionize the field, making surgeries more precise and less invasive.

Dec 11, 2023

FDA granted accelerated approval to Lilly’s Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma patients.

Dec 01, 2023

FDA recently approved Amgen’s Wezlana for various inflammatory conditions, marking the first biosimilar approval referencing the J&J Stelara.

Nov 29, 2023

Cryotherapy, a therapeutic technique utilizing extreme cold temperatures, has witnessed a significant evolution catalyzed by technological advancements, propelling its prominence in the healthcare industry. The integration of cutting-edge technology has revolutionized cryotherapy, enabling precise temperature contr...

Nov 27, 2023

The FDA has granted label extensions for two of the most vital global cancer drugs—Merck’s Keytruda and Pfizer and Astellas’ Xtandi.

Nov 24, 2023

On October 31, FDA approved Cosentyx hidradenitis suppurativa treatment, marking first approval of new biologic in nearly a decade.

Nov 22, 2023

In recent years, the joint reconstruction devices market within the realm of orthopedics has undergone a profound evolution, owing to the technological advancements and innovations that have revolutionized treatment modalities and patient outcomes to a much greater extent. The intersection of innovative technologie...

Nov 20, 2023

Within a three-day period, Phathom Pharmaceuticals achieves dual FDA approvals for Voquezna, its groundbreaking heartburn medication.